Antiretroviral drug market is anticipated to grow at a significant CAGR during the forecast period. Antiretrovirals are the class of drugs that are considered to be effective against the incidences of a retrovirus such as to treat HIV, in particular. The major factors that are primarily attributed to the growth of these drugs include the rising prevalence and burden of HIV infections all over the globe. According to the US Department of Health & Human Services, there were nearly 37.9 million people globally living with HIV/AIDS in 2018. An estimated 1.7 million individuals globally became newly infected with HIV in 2018.
Another key trends that drive the market growth include the increasing investment in the R&D of such drugs along with the increase in the availability of novel drugs with improved drug efficacy. These drugs are available in number of categories that majorly include integrase inhibitors, protease inhibitors, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and others. Among all these, Nucleoside Reverse Transcriptase Inhibitors (NRTIs) are likely to drive the market growth during the forecast period. Currently, antiretrovirals are considered to be the base of HIV/AIDS treatment, since there is no solid cure or a preventive vaccine available for HIV. In the case of a non-resistant strain of HIV, antiretroviral treatment can restrain the replication of HIV in the majority of cases. Thus, the presence of a huge patient pool demands anti-retroviral drugs for the treatment which is projected to drive the growth of the market during the forecast period.
To Request a Sample of our Report on Antiretroviral Drug Market: https://www.omrglobal.com/request-sample/antiretroviral-drug-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered
- Regions Covered- Globally
- Competitive Landscape: Bristol-Myers Squibb Co., Gilead Sciences, Inc., and Merck & Co., Inc., among others.
Antiretroviral Drug Market by Segments
By Drug Class
- Integrase Inhibitors
- Protease Inhibitors
- Multi-class Combination Products
- Nucleoside Reverse Transcriptase Inhibitors
- Non-Nucleoside Reverse Transcriptase Inhibitors
- Others
A full Report of Antiretroviral Drug Market is Available at: https://www.omrglobal.com/industry-reports/antiretroviral-drug-market
Antiretroviral Drug Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
